Cargando…

Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination

Conditional gene targeting using the Cre-loxp system is a well established technique in numerous in vitro and in vivo systems. Ligand regulated forms of Cre have been increasingly used in these applications in order to gain temporal and spatial control over conditional targeting. The tamoxifen-regul...

Descripción completa

Detalles Bibliográficos
Autores principales: Buelow, Ben, Scharenberg, Andrew M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533124/
https://www.ncbi.nlm.nih.gov/pubmed/18810268
http://dx.doi.org/10.1371/journal.pone.0003264
_version_ 1782159020589580288
author Buelow, Ben
Scharenberg, Andrew M.
author_facet Buelow, Ben
Scharenberg, Andrew M.
author_sort Buelow, Ben
collection PubMed
description Conditional gene targeting using the Cre-loxp system is a well established technique in numerous in vitro and in vivo systems. Ligand regulated forms of Cre have been increasingly used in these applications in order to gain temporal and spatial control over conditional targeting. The tamoxifen-regulated Cre variant mer-Cre-mer (mCrem) is widely utilized because of its reputation for tight regulation in the absence of its tamoxifen ligand. In the DT40 chicken B cell line, we generated an mCrem-based reversible switch for conditional regulation of a transgene, and in contrast with previous work, observed significant constitutive activity of mCrem. This prompted us to use our system for analysis of the parameters governing tamoxifen-regulated mCrem recombination of a genomic target. We find that robust mCrem expression correlates with a high level of tamoxifen-independent Cre activity, while clones expressing mCrem at the limit of western blot detection exhibit extremely tight regulation. We also observe time and dose-dependent effects on mCrem activity which suggest limitations on the use of conditional targeting approaches for applications which require tight temporal coordination of Cre action within a cell population.
format Text
id pubmed-2533124
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-25331242008-09-23 Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination Buelow, Ben Scharenberg, Andrew M. PLoS One Research Article Conditional gene targeting using the Cre-loxp system is a well established technique in numerous in vitro and in vivo systems. Ligand regulated forms of Cre have been increasingly used in these applications in order to gain temporal and spatial control over conditional targeting. The tamoxifen-regulated Cre variant mer-Cre-mer (mCrem) is widely utilized because of its reputation for tight regulation in the absence of its tamoxifen ligand. In the DT40 chicken B cell line, we generated an mCrem-based reversible switch for conditional regulation of a transgene, and in contrast with previous work, observed significant constitutive activity of mCrem. This prompted us to use our system for analysis of the parameters governing tamoxifen-regulated mCrem recombination of a genomic target. We find that robust mCrem expression correlates with a high level of tamoxifen-independent Cre activity, while clones expressing mCrem at the limit of western blot detection exhibit extremely tight regulation. We also observe time and dose-dependent effects on mCrem activity which suggest limitations on the use of conditional targeting approaches for applications which require tight temporal coordination of Cre action within a cell population. Public Library of Science 2008-09-23 /pmc/articles/PMC2533124/ /pubmed/18810268 http://dx.doi.org/10.1371/journal.pone.0003264 Text en Buelow, Scharenberg. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Buelow, Ben
Scharenberg, Andrew M.
Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination
title Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination
title_full Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination
title_fullStr Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination
title_full_unstemmed Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination
title_short Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination
title_sort characterization of parameters required for effective use of tamoxifen-regulated recombination
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533124/
https://www.ncbi.nlm.nih.gov/pubmed/18810268
http://dx.doi.org/10.1371/journal.pone.0003264
work_keys_str_mv AT buelowben characterizationofparametersrequiredforeffectiveuseoftamoxifenregulatedrecombination
AT scharenbergandrewm characterizationofparametersrequiredforeffectiveuseoftamoxifenregulatedrecombination